mutation
→
ReceivesAction
→
inherited
|
0.66
|
|
mutation
→
ReceivesAction
→
shown in table
|
0.66
|
|
mutation
→
ReceivesAction
→
associated with resistance
|
0.66
|
|
mutation
→
ReceivesAction
→
confirmed
|
0.63
|
|
mutation
→
ReceivesAction
→
selected
|
0.63
|
|
mutation
→
ReceivesAction
→
confirmed by dna sequencing
|
0.62
|
|
mutation
→
ReceivesAction
→
confirmed by sanger sequencing
|
0.61
|
|
mutation
→
ReceivesAction
→
associated with disease
|
0.61
|
|
mutation
→
ReceivesAction
→
tested
|
0.61
|
|
mutation
→
ReceivesAction
→
favored by natural selection
|
0.59
|
|
mutation
→
ReceivesAction
→
identified
|
0.58
|
|
mutation
→
ReceivesAction
→
distributed
|
0.58
|
|
mutation
→
ReceivesAction
→
detected
|
0.58
|
|
mutation
→
ReceivesAction
→
removed
|
0.58
|
|
mutation
→
ReceivesAction
→
verified
|
0.57
|
|
mutation
→
ReceivesAction
→
identified in patient
|
0.57
|
|
mutation
→
ReceivesAction
→
reported
|
0.57
|
|
mutation
→
ReceivesAction
→
linked to breast cancer
|
0.56
|
|
mutation
→
ReceivesAction
→
studied
|
0.56
|
|
mutation
→
ReceivesAction
→
caused by mutagen
|
0.55
|
|
mutation
→
ReceivesAction
→
generated by site-directed muta…
|
0.55
|
|
mutation
→
ReceivesAction
→
shown
|
0.55
|
|
mutation
→
ReceivesAction
→
likely to occur
|
0.55
|
|
mutation
→
ReceivesAction
→
described
|
0.54
|
|
mutation
→
ReceivesAction
→
passed on to offspring
|
0.54
|
|
mutation
→
ReceivesAction
→
associated with cancer
|
0.53
|
|
mutation
→
ReceivesAction
→
inherited in autosomal dominant…
|
0.52
|
|
mutation
→
ReceivesAction
→
discovered
|
0.52
|
|
mutation
→
ReceivesAction
→
reported in patient
|
0.52
|
|
mutation
→
ReceivesAction
→
associated with drug resistance
|
0.52
|
|
mutation
→
ReceivesAction
→
associated with aml
|
0.51
|
|
mutation
→
ReceivesAction
→
described in the literature
|
0.51
|
|
mutation
→
ReceivesAction
→
associated with the disease
|
0.51
|
|
mutation
→
ReceivesAction
→
detected by direct sequencing
|
0.51
|
|
mutation
→
ReceivesAction
→
corrected
|
0.50
|
|
mutation
→
ReceivesAction
→
tolerated
|
0.50
|
|
mutation
→
ReceivesAction
→
identified by wes
|
0.50
|
|
mutation
→
ReceivesAction
→
identified in tumor
|
0.50
|
|
mutation
→
ReceivesAction
→
reversed
|
0.50
|
|
mutation
→
ReceivesAction
→
traced
|
0.50
|
|
mutation
→
ReceivesAction
→
linked to pd
|
0.49
|
|
mutation
→
ReceivesAction
→
confirmed by pcr
|
0.49
|
|
mutation
→
ReceivesAction
→
taken into account
|
0.49
|
|
mutation
→
ReceivesAction
→
introduced
|
0.49
|
|
mutation
→
ReceivesAction
→
associated with autism
|
0.49
|
|
mutation
→
ReceivesAction
→
linked to breast
|
0.48
|
|
mutation
→
ReceivesAction
→
added
|
0.48
|
|
mutation
→
ReceivesAction
→
predicted to be deleterious
|
0.48
|
|
mutation
→
ReceivesAction
→
removed by natural selection
|
0.47
|
|
mutation
→
ReceivesAction
→
identified to date
|
0.47
|
|
mutation
→
ReceivesAction
→
confirmed by dna sequence analy…
|
0.47
|
|
mutation
→
ReceivesAction
→
described in methods
|
0.47
|
|
mutation
→
ReceivesAction
→
associated to date
|
0.46
|
|
mutation
→
ReceivesAction
→
associated with inh resistance
|
0.46
|
|
mutation
→
ReceivesAction
→
associated with hearing loss
|
0.46
|
|
mutation
→
ReceivesAction
→
described to date
|
0.46
|
|
mutation
→
ReceivesAction
→
clustered in exon
|
0.46
|
|
mutation
→
ReceivesAction
→
fixed
|
0.45
|
|
mutation
→
ReceivesAction
→
common in the ashkenazi populat…
|
0.45
|
|
mutation
→
ReceivesAction
→
taken per four mutator levels
|
0.45
|
|
mutation
→
ReceivesAction
→
correlated with ovarian cancer
|
0.45
|
|
mutation
→
ReceivesAction
→
lost
|
0.45
|
|
mutation
→
ReceivesAction
→
caused by radiation
|
0.45
|
|
mutation
→
ReceivesAction
→
associated with sensitivity
|
0.45
|
|
mutation
→
ReceivesAction
→
observed
|
0.44
|
|
mutation
→
ReceivesAction
→
implicated
|
0.44
|
|
mutation
→
ReceivesAction
→
linked to schizophrenia
|
0.44
|
|
mutation
→
ReceivesAction
→
eliminated
|
0.44
|
|
mutation
→
ReceivesAction
→
identified in people
|
0.44
|
|
mutation
→
ReceivesAction
→
linked
|
0.44
|
|
mutation
→
ReceivesAction
→
predicted to be damaging
|
0.44
|
|
mutation
→
ReceivesAction
→
associated with mild phenotype
|
0.44
|
|
mutation
→
ReceivesAction
→
confirmed by bidirectional sequ…
|
0.44
|
|
mutation
→
ReceivesAction
→
detected by the kit
|
0.44
|
|
mutation
→
ReceivesAction
→
listed in additional file
|
0.44
|
|
mutation
→
ReceivesAction
→
validated by sanger
|
0.44
|
|
mutation
→
ReceivesAction
→
excluded
|
0.44
|
|
mutation
→
ReceivesAction
→
rejected
|
0.44
|
|
mutation
→
ReceivesAction
→
maintained in the population
|
0.42
|
|
mutation
→
ReceivesAction
→
detected at high frequency
|
0.42
|
|
mutation
→
ReceivesAction
→
involved in different families
|
0.42
|
|
mutation
→
ReceivesAction
→
written
|
0.42
|
|
mutation
→
ReceivesAction
→
associated with dwarfism
|
0.42
|
|
mutation
→
ReceivesAction
→
caused by dna damage
|
0.42
|
|
mutation
→
ReceivesAction
→
passed to child
|
0.42
|
|
mutation
→
ReceivesAction
→
underlined
|
0.41
|
|
mutation
→
ReceivesAction
→
associated with fmf
|
0.41
|
|
mutation
→
ReceivesAction
→
associated with starting protein
|
0.41
|
|
mutation
→
ReceivesAction
→
confirmed to be somatic
|
0.41
|
|
mutation
→
ReceivesAction
→
passed on to future generations
|
0.41
|
|
mutation
→
ReceivesAction
→
noted in red
|
0.41
|
|
mutation
→
ReceivesAction
→
caused by transposon
|
0.41
|
|
mutation
→
ReceivesAction
→
identified in gene
|
0.41
|
|
mutation
→
ReceivesAction
→
passed
|
0.40
|
|
mutation
→
ReceivesAction
→
seen in our cohort
|
0.40
|
|
mutation
→
ReceivesAction
→
missed
|
0.40
|
|
mutation
→
ReceivesAction
→
recognized
|
0.40
|
|
mutation
→
ReceivesAction
→
accumulated
|
0.40
|
|
mutation
→
ReceivesAction
→
induced by bcnu
|
0.40
|
|
mutation
→
ReceivesAction
→
induced by acnu
|
0.39
|
|
mutation
→
ReceivesAction
→
present in parent
|
0.39
|
|
mutation
→
ReceivesAction
→
reported in individual
|
0.39
|
|
mutation
→
ReceivesAction
→
caused by virus
|
0.39
|
|
mutation
→
ReceivesAction
→
required to cause disease
|
0.38
|
|
mutation
→
ReceivesAction
→
common in general population
|
0.38
|
|
mutation
→
ReceivesAction
→
caused by favipiravir
|
0.38
|
|
mutation
→
ReceivesAction
→
identified in 2014
|
0.38
|
|
mutation
→
ReceivesAction
→
associated with congenital cata…
|
0.38
|
|
mutation
→
ReceivesAction
→
likely to lead
|
0.38
|
|
mutation
→
ReceivesAction
→
mapped to chromosome
|
0.38
|
|
mutation
→
ReceivesAction
→
implicated in human
|
0.37
|
|
mutation
→
ReceivesAction
→
linked to leukemia
|
0.37
|
|
mutation
→
ReceivesAction
→
identified in lung adenocarcino…
|
0.37
|
|
mutation
→
ReceivesAction
→
shared
|
0.37
|
|
mutation
→
ReceivesAction
→
inherited in autosomal recessiv…
|
0.36
|
|
mutation
→
ReceivesAction
→
associated with alzheimer's dis…
|
0.36
|
|
mutation
→
ReceivesAction
→
associated with condition
|
0.35
|
|
mutation
→
ReceivesAction
→
associated with lymphedema
|
0.35
|
|
mutation
→
ReceivesAction
→
common in other tumor types
|
0.35
|
|
mutation
→
ReceivesAction
→
located on long arm of chromoso…
|
0.35
|
|
mutation
→
ReceivesAction
→
associated with poor prognosis
|
0.35
|
|
mutation
→
ReceivesAction
→
associated with other cancers
|
0.35
|
|
mutation
→
ReceivesAction
→
identified in proband
|
0.35
|
|
mutation
→
ReceivesAction
→
associated with poorer outcomes
|
0.34
|
|
mutation
→
ReceivesAction
→
associated with prostate
|
0.34
|
|
mutation
→
ReceivesAction
→
distributed throughout the gene
|
0.34
|
|
mutation
→
ReceivesAction
→
identified in atm
|
0.34
|
|
mutation
→
ReceivesAction
→
informative to identify and cla…
|
0.34
|
|
mutation
→
ReceivesAction
→
shown in fig
|
0.34
|
|
mutation
→
ReceivesAction
→
caused by chemical
|
0.34
|
|
mutation
→
ReceivesAction
→
expected
|
0.34
|
|
mutation
→
ReceivesAction
→
caused by error
|
0.33
|
|
mutation
→
ReceivesAction
→
a consequence of replication in…
|
0.33
|
|
mutation
→
ReceivesAction
→
associated with af
|
0.33
|
|
mutation
→
ReceivesAction
→
detected by ngs
|
0.33
|
|
mutation
→
ReceivesAction
→
released into a gene pool
|
0.33
|
|
mutation
→
ReceivesAction
→
scattered throughout the genome
|
0.33
|
|
mutation
→
ReceivesAction
→
accumulated over time
|
0.32
|
|
mutation
→
ReceivesAction
→
annotated
|
0.32
|
|
mutation
→
ReceivesAction
→
associated with ahus
|
0.32
|
|
mutation
→
ReceivesAction
→
associated with fh
|
0.32
|
|
mutation
→
ReceivesAction
→
associated with lgmd
|
0.32
|
|
mutation
→
ReceivesAction
→
caused by environmental factors
|
0.32
|
|
mutation
→
ReceivesAction
→
deemed random
|
0.32
|
|
mutation
→
ReceivesAction
→
detected in three patients
|
0.32
|
|
mutation
→
ReceivesAction
→
followed by loss of heterozygos…
|
0.32
|
|
mutation
→
ReceivesAction
→
implicated in pancreatic cancer
|
0.32
|
|
mutation
→
ReceivesAction
→
induced by new mutagenesis tech…
|
0.32
|
|
mutation
→
ReceivesAction
→
sequenced
|
0.32
|
|
mutation
→
ReceivesAction
→
shown on branch
|
0.32
|
|
mutation
→
ReceivesAction
→
caused by smoking
|
0.32
|
|
mutation
→
ReceivesAction
→
associated with diabetes
|
0.32
|
|
mutation
→
ReceivesAction
→
associated with lynch syndrome
|
0.32
|
|
mutation
→
ReceivesAction
→
associated with antimicrobial r…
|
0.31
|
|
mutation
→
ReceivesAction
→
carried by the patient
|
0.31
|
|
mutation
→
ReceivesAction
→
characterised by dominant or se…
|
0.31
|
|
mutation
→
ReceivesAction
→
color-coded
|
0.31
|
|
mutation
→
ReceivesAction
→
incorporated
|
0.31
|
|
mutation
→
ReceivesAction
→
likely to affect genes
|
0.31
|
|
mutation
→
ReceivesAction
→
likely to cause a radical change
|
0.31
|
|
mutation
→
ReceivesAction
→
masked by later ones
|
0.31
|
|
mutation
→
ReceivesAction
→
present in all affected living …
|
0.31
|
|
mutation
→
ReceivesAction
→
present in all of the body's ce…
|
0.31
|
|
mutation
→
ReceivesAction
→
caused by exposure
|
0.31
|
|
mutation
→
ReceivesAction
→
observed in brazil
|
0.29
|
|
mutation
→
ReceivesAction
→
shown in blue
|
0.29
|
|
mutation
→
ReceivesAction
→
treated with gefitinib
|
0.29
|
|
mutation
→
ReceivesAction
→
associated with increased risk
|
0.29
|
|
mutation
→
ReceivesAction
→
associated with acute myeloid l…
|
0.29
|
|
mutation
→
ReceivesAction
→
associated with frontotemporal …
|
0.29
|
|
mutation
→
ReceivesAction
→
correlated with colorectal
|
0.29
|
|
mutation
→
ReceivesAction
→
difficult to detect
|
0.29
|
|
mutation
→
ReceivesAction
→
associated with cardiomyopathy
|
0.28
|
|
mutation
→
ReceivesAction
→
associated with obesity
|
0.27
|
|
mutation
→
ReceivesAction
→
associated with alkaptonuria
|
0.27
|
|
mutation
→
ReceivesAction
→
associated with aniridia
|
0.27
|
|
mutation
→
ReceivesAction
→
associated with delayed parasit…
|
0.27
|
|
mutation
→
ReceivesAction
→
associated with first- and seco…
|
0.27
|
|
mutation
→
ReceivesAction
→
associated with gbm
|
0.27
|
|
mutation
→
ReceivesAction
→
associated with increased ovula…
|
0.27
|
|
mutation
→
ReceivesAction
→
associated with isoniazid resis…
|
0.27
|
|
mutation
→
ReceivesAction
→
associated with primary resista…
|
0.27
|
|
mutation
→
ReceivesAction
→
associated with renal cysts
|
0.27
|
|
mutation
→
ReceivesAction
→
associated with rifampicin resi…
|
0.27
|
|
mutation
→
ReceivesAction
→
carried by neoplastic clone
|
0.27
|
|
mutation
→
ReceivesAction
→
correlated
|
0.27
|
|
mutation
→
ReceivesAction
→
highlighted
|
0.27
|
|
mutation
→
ReceivesAction
→
involved in binding to csp
|
0.27
|
|
mutation
→
ReceivesAction
→
kept in check
|
0.27
|
|
mutation
→
ReceivesAction
→
limited
|
0.27
|
|
mutation
→
ReceivesAction
→
linked to cpvt
|
0.27
|
|
mutation
→
ReceivesAction
→
neglected
|
0.27
|
|
mutation
→
ReceivesAction
→
replicated
|
0.27
|
|
mutation
→
ReceivesAction
→
reported in the hgmd
|
0.27
|
|
mutation
→
ReceivesAction
→
responsible for alagille syndro…
|
0.27
|
|
mutation
→
ReceivesAction
→
shaded
|
0.27
|
|
mutation
→
ReceivesAction
→
never be avoided
|
0.27
|
|
mutation
→
ReceivesAction
→
discussed
|
0.25
|
|
mutation
→
ReceivesAction
→
acquired by smooth muscle cells
|
0.25
|
|
mutation
→
ReceivesAction
→
associated with antifolate resi…
|
0.25
|
|
mutation
→
ReceivesAction
→
associated with ars type
|
0.25
|
|
mutation
→
ReceivesAction
→
associated with benign genetic …
|
0.25
|
|
mutation
→
ReceivesAction
→
associated with cadasil syndrome
|
0.25
|
|
mutation
→
ReceivesAction
→
associated with crohn’s disease
|
0.25
|
|
mutation
→
ReceivesAction
→
associated with dcm
|
0.25
|
|
mutation
→
ReceivesAction
→
associated with familial hemipl…
|
0.25
|
|
mutation
→
ReceivesAction
→
associated with harp syndrome
|
0.25
|
|
mutation
→
ReceivesAction
→
associated with mesothelioma
|
0.25
|
|
mutation
→
ReceivesAction
→
associated with pcg
|
0.25
|
|
mutation
→
ReceivesAction
→
associated with pmf
|
0.25
|
|
mutation
→
ReceivesAction
→
buffered
|
0.25
|
|
mutation
→
ReceivesAction
→
carried by all 18 men
|
0.25
|
|
mutation
→
ReceivesAction
→
carried by related breeds
|
0.25
|
|
mutation
→
ReceivesAction
→
caused by cosmic rays
|
0.25
|
|
mutation
→
ReceivesAction
→
classified as level
|
0.25
|
|
mutation
→
ReceivesAction
→
classified into two groups
|
0.25
|
|
mutation
→
ReceivesAction
→
created at predefined points
|
0.25
|
|
mutation
→
ReceivesAction
→
detected at baseline
|
0.25
|
|
mutation
→
ReceivesAction
→
detected by d-hplc/ds
|
0.25
|
|
mutation
→
ReceivesAction
→
detected by hrm
|
0.25
|
|
mutation
→
ReceivesAction
→
detected by whole genome
|
0.25
|
|
mutation
→
ReceivesAction
→
discovered in 2013
|
0.25
|
|
mutation
→
ReceivesAction
→
easy to detect
|
0.25
|
|
mutation
→
ReceivesAction
→
enriched in tumor
|
0.25
|
|
mutation
→
ReceivesAction
→
found within large dna regions
|
0.25
|
|
mutation
→
ReceivesAction
→
fused in sarcoma
|
0.25
|
|
mutation
→
ReceivesAction
→
identified by exome sequencing
|
0.25
|
|
mutation
→
ReceivesAction
→
identified in 2009
|
0.25
|
|
mutation
→
ReceivesAction
→
identified in cataractogenesis
|
0.25
|
|
mutation
→
ReceivesAction
→
identified in patients of europ…
|
0.25
|
|
mutation
→
ReceivesAction
→
identified in to3 mouse mutant
|
0.25
|
|
mutation
→
ReceivesAction
→
induced by ethylnitrosourea
|
0.25
|
|
mutation
→
ReceivesAction
→
induced by gamma radiation
|
0.25
|
|
mutation
→
ReceivesAction
→
involved in the buildup of subs…
|
0.25
|
|
mutation
→
ReceivesAction
→
isolated in genetic screens
|
0.25
|
|
mutation
→
ReceivesAction
→
likely to be non
|
0.25
|
|
mutation
→
ReceivesAction
→
linked to dyskeratosis congenita
|
0.25
|
|
mutation
→
ReceivesAction
→
listed below the haplogroup name
|
0.25
|
|
mutation
→
ReceivesAction
→
made in single cycle of hiv-1 r…
|
0.25
|
|
mutation
→
ReceivesAction
→
needed to confer some ability
|
0.25
|
|
mutation
→
ReceivesAction
→
predicted by polyphen-2
|
0.25
|
|
mutation
→
ReceivesAction
→
present in two archaic samples
|
0.25
|
|
mutation
→
ReceivesAction
→
prioritized
|
0.25
|
|
mutation
→
ReceivesAction
→
propagated to new generations o…
|
0.25
|
|
mutation
→
ReceivesAction
→
reported in two other turkish f…
|
0.25
|
|
mutation
→
ReceivesAction
→
seen in two other children
|
0.25
|
|
mutation
→
ReceivesAction
→
selected in all of the evolutio…
|
0.25
|
|
mutation
→
ReceivesAction
→
shown above structural domains
|
0.25
|
|
mutation
→
ReceivesAction
→
subject to genetic drift
|
0.25
|
|
mutation
→
ReceivesAction
→
transmitted to large numbers of…
|
0.25
|
|
mutation
→
ReceivesAction
→
treated with erlotinib
|
0.25
|
|
mutation
→
ReceivesAction
→
unlinked
|
0.25
|
|
mutation
→
ReceivesAction
→
linked to depression
|
0.25
|
|
mutation
→
ReceivesAction
→
identified in affected individu…
|
0.24
|
|
mutation
→
ReceivesAction
→
indicated by asterisk
|
0.24
|
|
mutation
→
ReceivesAction
→
associated with immunodeficiency
|
0.24
|
|
mutation
→
ReceivesAction
→
correlated with gastric
|
0.24
|
|
mutation
→
ReceivesAction
→
correlated with thyroid
|
0.24
|
|
mutation
→
ReceivesAction
→
located on the x chromosome
|
0.24
|
|
mutation
→
ReceivesAction
→
seen in skeletal muscle
|
0.23
|
|
mutation
→
ReceivesAction
→
associated with atherosclerosis
|
0.22
|
|
mutation
→
ReceivesAction
→
associated with type 2 diabetes
|
0.22
|
|
mutation
→
ReceivesAction
→
determined by genetic test
|
0.22
|
|
mutation
→
ReceivesAction
→
linked to cardiovascular disease
|
0.22
|
|
mutation
→
ReceivesAction
→
never selected
|
0.22
|
|
mutation
→
ReceivesAction
→
associated with malignant hyper…
|
0.21
|
|
mutation
→
ReceivesAction
→
caused by physical agents
|
0.21
|
|
mutation
→
ReceivesAction
→
associated with metastasis
|
0.20
|
|
mutation
→
ReceivesAction
→
associated with ad
|
0.19
|
|
mutation
→
ReceivesAction
→
associated with survival
|
0.19
|
|
mutation
→
ReceivesAction
→
associated with asthma
|
0.19
|
|
mutation
→
ReceivesAction
→
associated with charcot-marie-t…
|
0.19
|
|
mutation
→
ReceivesAction
→
associated with hepatocellular …
|
0.19
|
|
mutation
→
ReceivesAction
→
associated with the cone-rod dy…
|
0.19
|
|
mutation
→
ReceivesAction
→
linked to lymphoma
|
0.19
|
|
mutation
→
ReceivesAction
→
detected in contrast
|
0.18
|
|
mutation
→
ReceivesAction
→
associated with artemisinin res…
|
0.17
|
|
mutation
→
ReceivesAction
→
associated with aggressive mast…
|
0.16
|
|
mutation
→
ReceivesAction
→
associated with altered distrib…
|
0.16
|
|
mutation
→
ReceivesAction
→
associated with angiogenesis
|
0.16
|
|
mutation
→
ReceivesAction
→
associated with autosomal domin…
|
0.16
|
|
mutation
→
ReceivesAction
→
associated with earlier onset o…
|
0.16
|
|
mutation
→
ReceivesAction
→
associated with elevated total …
|
0.16
|
|
mutation
→
ReceivesAction
→
associated with fluoroquinolone…
|
0.16
|
|
mutation
→
ReceivesAction
→
associated with long qt syndrome
|
0.16
|
|
mutation
→
ReceivesAction
→
associated with mastocytosis
|
0.16
|
|
mutation
→
ReceivesAction
→
associated with non-hodgkin lym…
|
0.16
|
|
mutation
→
ReceivesAction
→
associated with peripheral neur…
|
0.16
|
|
mutation
→
ReceivesAction
→
associated with reduced enzyme …
|
0.16
|
|
mutation
→
ReceivesAction
→
associated with sudden cardiac …
|
0.16
|
|
mutation
→
ReceivesAction
→
carried to actual genetic damage
|
0.16
|
|
mutation
→
ReceivesAction
→
caused by sunlight
|
0.16
|
|
mutation
→
ReceivesAction
→
detected on exosome rna
|
0.16
|
|
mutation
→
ReceivesAction
→
identified in skin lesions
|
0.16
|
|
mutation
→
ReceivesAction
→
linked with spontaneous, non-in…
|
0.16
|
|
mutation
→
ReceivesAction
→
predicted to be damaging by sift
|
0.16
|
|
mutation
→
ReceivesAction
→
reported in the abca1 gene
|
0.16
|
|
mutation
→
ReceivesAction
→
responsible for hirschsprung di…
|
0.16
|
|
mutation
→
ReceivesAction
→
used to profile fusion
|
0.16
|
|
mutation
→
ReceivesAction
→
used to profile splice variants
|
0.16
|
|
mutation
→
ReceivesAction
→
detected in rps14
|
0.15
|
|
mutation
→
ReceivesAction
→
identified by sequence analysis
|
0.15
|
|
mutation
→
ReceivesAction
→
associated with drug sensitivity
|
0.13
|
|
mutation
→
ReceivesAction
→
associated with poag
|
0.11
|
|
mutation
→
ReceivesAction
→
associated with lamivudine resi…
|
0.09
|
|
mutation
→
ReceivesAction
→
associated with nnrti resistance
|
0.09
|
|
mutation
→
ReceivesAction
→
identified by tes
|
0.09
|
|
mutation
→
ReceivesAction
→
identified in the tau gene
|
0.09
|
|